Show metadata Hide metadata

(19)

(11)

2 773 357

(13)

(51)

IPC

A61K39/00(2006-01-01)

A61K39/12(2006-01-01)

A61K39/29(2006-01-01)

(21) (22)

Application

2020115051, 2018-10-04

(24)

Start date

2018-10-04

(22)

Actual filing date

2018-10-04

(45)

Published

2022-06-02

(72)

Inventor

Kamishita, TaizouMiyazaki, TakashiKohara, MichinoriSanada, TakahiroHiasa, YoichiYoshida, OsamuKohara, KyokoHasegawa, Hideki

(73)

Holder

Toko Yakuhin Kogyo Co., Ltd.Tokyo Metropolitan Institute Of Medical ScienceJapan As Represented By Director General Of National Institute Of Infectious DiseasesKagoshima UniversityNational University Corporation Ehime University

NASAL VACCINE COMPOSITION AGAINST HEPATITIS B AND ITS PRODUCTION METHOD Russian patent published in 2022 - IPC A61K39/00 A61K39/12 A61K39/29

Abstract RU 2773357 C2

FIELD: biotechnology.

SUBSTANCE: present invention relates to biotechnology, in particular a vaccine composition against hepatitis B for application in the form of a spray to nasal mucosa for the prevention and treatment of hepatitis B, which includes a hepatitis B antigen and carboxyvinyl polymer.

EFFECT: obtaining a nasal vaccine composition for the treatment of hepatitis B.

10 cl, 2 dwg, 1 tbl, 1 ex

Similar patents RU2773357C2

Title	Year	Author	Number
HEPATITIS B VACCINE TRANSNASAL SYSTEM	2019	Kamishita, Taizou Miyazaki, Takashi Hiasa, Yoichi Sheikh Mohammad, Fazle Akbar Yoshida, Osamu Aguilar Rubido, Julio Cesar Guillen Nieto, Gerardo Enrique Penton Arias, Eduardo	RU2795235C2
NASAL INFLUENZA VACCINE COMPOSITION	2013	Khasegava Khideki Suzuki Tadaki Ainai Akira Kamisita Taidzou Miyazaki Takasi	RU2652296C2
MUCOSAL VACCINE	2011	Kido Khiroshi Midzuno Daj	RU2570394C2
RHINOVACCINATION SYSTEM FOR INFLUENZA VACCINE	2015	Kamishita, Taizou Miyazaki, Takashi	RU2696483C2
MUCOSAL INFLUENZA VIRUS VACCINE AND METHOD FOR INFLUENZA PREVENTION	2004	Khasegava Khideki Kurata Takesi Sata Tetsutarou Morijama Masami Tamura Sin-Iti Tanimoto Takefumi	RU2390351C2
MEDICINAL ANTIGEN CARRIER ENABLING TRANSMUCOSAL AND TRANSDERMAL ADMINISTRATION, METHOD OF MUCOSAL IMMUNITY INDUCTION, MUCOSAL VACCINE AND RELATED DRUG DELIVERY SYSTEM	2005	Kido Khiroshi Midzuno Daj	RU2396090C2
ADJUVANT COMPOSITION CONTAINING POLY-GAMMA-GLUTAMIC ACID	2005	Sung Mun Khe Kim Chjul Dzoong Pu Kha Roung Khong Syng Po Li Dzong Su Kim Dzy Uon	RU2390352C2
AGENTS AND METHODS OF TREATING HEPATITIS B VIRUS	2017	Protser Ulrike Bauer Tanya Kosinska Anna Myuk-Khejsl Martin	RU2740802C2
COMPLEX FOR ENHANCING IMMUNE RESPONSE	2019	Lin, Haixiang Liu, Fang Zha, Li	RU2779622C2
INTRANASAL VACCINE INDUCING CELL-MEDIATED IMMUNITY	2019	Yuki, Esikadzu Nakakhasi, Rika Kieno, Khirosi	RU2796973C2

RU 2 773 357 C2

Authors

Kamishita, Taizou

Miyazaki, Takashi

Kohara, Michinori

Sanada, Takahiro

Hiasa, Yoichi

Yoshida, Osamu

Kohara, Kyoko

Hasegawa, Hideki

Dates

2022-06-02—Published

2018-10-04—Filed